Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
8th International Conference on Alzheimer's Disease and Related Disorders:   Dennis Selkoe

Updated 5 November 2002

Return to 8th International Conference Index

The Life Cycle of Ab: Production and Degradation
By Dennis J. Selkoe

   View Dennis Selkoe's presentation

Abstract: Although elevated brain levels of Ab occur universally in AD, only a minority of cases involves increased Ab production, primarily those with presenilin mutations. Therefore, defects in proteases that degrade Ab could underlie some cases of familial and sporadic AD. An unbiased screen of cultured cells for Ab-degrading proteases previously revealed IDE as the principal protease that degrades naturally secreted Aß in both neuronal and microglial cultures (Qiu et al, JBC, 1997, 1998). We have now assayed Ab-degrading capacity in total homogenates and membrane fractions of normal and AD brains. The degree of Ab degradation correlated inversely the levels of soluble but not insoluble Ab in the tissue. Insulin, the most avid substrate of IDE, inhibited Ab-degrading activity ~70% in the membrane fraction of human brain, whereas thiorphan and phosphoramidon, inhibitors of neprilysin, blocked ~25%. In mouse brain membrane fractions, Ab degradation was similarly inhibited ~70% by insulin and ~30% by thiorphan. Subcellular fractionation of IDE-transfected cells revealed that membrane-associated IDE lowered the levels of endogenous intracellular Ab in the vesicles that generate the peptide. Thus, accruing evidence that IDE can degrade Ab in neural and microglial cultures and in human brain recommended it as a candidate FAD gene. A collaborative study provided evidence of linkage of markers flanking the IDE gene on chromosome 10q to AD in the NIMH families (Bertram et al, Science, 2000). 125I-Ab40 degradation in whole lymphoblast cultures from a subset of the linked families and unrelated controls is now being quantified. We conclude that IDE plays a role in Ab degradation, both intra- and extracellularly, and that neprilysin also contributes to membrane-associated degradation in human and mouse brain. Further study of IDE will be relevant to Ab regulation in AD, whether or not IDE is ultimately found to be genetically implicated.

View Dennis Selkoe's presentation
To hear the associated audio, click on the "Play Audio" button on each slide.





Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad